Clinical Trials Directory

Trials / Completed

CompletedNCT02831270

Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery

Does Acute Normovolemic Hemodilution Affect Intraoperative Value of Serum-creatinine Concentration in Patients Undergoing Cardiac Surgery?

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Konkuk University Medical Center · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Serum-creatinine level (s-Cr) is an important factor for predicting perioperative patient's outcome regarding acute kidney injury. Although cardiopulmonary bypass (CPB), an essential procedure for cardiac surgery, dilutes patient's blood components, possible impact of applying acute normovolemic hemodilution (ANH) and CPB on s-Cr has not been well investigated. In patients undergoing cardiac surgery employing moderate hypothermic CPB (age 20-71 years, n=32), ANH will be randomly applied to 15 patients (Group-ANH) but not in 17 patients (Group-C) before initiating CPB. For ANH procedure consisting of 5 ml/kg of blood salvage and administering 5 ml/kg of balanced hydroxyethyl starch (HES) 130/0.4 for 15 min will be started at 30 min after anesthesia induction and before CPB application for surgery. In both groups, moderate hypothermic CPB will be initiated by using 1600-1800 ml of bloodless priming solution. The changes of hematocrit (Hct), Na+, K+, HCO3-, Ca2+, osmolarity, s-Cr will be determined before ANH (T1), after the first ANH of 2.5 ml/kg (T2), and after the second ANH of 2.5 ml/kg (T3), 30 sec and 60 sec after the initiation of CPB (T4, T5), immediately and 1 hour after the weaning from CPB (T6, T7) and at the end of surgery (T8). S-Cr will be determined by using a point-of-care test device (StatSensor™ Creatinine, Nova Biomedical, USA).

Conditions

Interventions

TypeNameDescription
PROCEDUREAcute normovolemic hemodilution (ANH)
DRUGhydroxyethyl starch (HES 130/0.6)

Timeline

Start date
2011-12-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-07-13
Last updated
2016-07-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02831270. Inclusion in this directory is not an endorsement.